These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6704509)

  • 1. Metabolites decrease the plasma clearance of isosorbide dinitrate in rats.
    Sutton SC; Fung HL
    Biopharm Drug Dispos; 1984; 5(1):85-9. PubMed ID: 6704509
    [No Abstract]   [Full Text] [Related]  

  • 2. Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.
    Morrison RA; Fung HL
    J Pharmacol Exp Ther; 1984 Oct; 231(1):124-30. PubMed ID: 6491969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of standard and nicotine-reduced cigarette smoke on plasma concentrations of isosorbide dinitrate and its metabolites in rats.
    Gomita Y; Furuno K; Araki Y
    J Pharm Pharmacol; 1991 Nov; 43(11):811-2. PubMed ID: 1686914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of isosorbide dinitrate inhibits arterial thrombosis in rats.
    Plotkine M; Allix M; Guillou J; Boulu R
    Eur J Pharmacol; 1991 Aug; 201(1):115-6. PubMed ID: 1794412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of electric foot shock on pharmacokinetics of isosorbide dinitrate subcutaneously administered to rats.
    Gomita Y; Furuno K; Araki Y
    Jpn J Pharmacol; 1989 Sep; 51(1):132-5. PubMed ID: 2810934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of isosorbide dinitrate in the isolated perfused rabbit lung.
    Mayer PR; Lubawy WC; McNamara PJ; Kostenbauder HB
    J Pharm Sci; 1983 Jul; 72(7):785-9. PubMed ID: 6886987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of electric foot shock on pharmacokinetics of isosorbide dinitrate orally administered to rats.
    Gomita Y; Furuno K; Araki Y
    Jpn J Pharmacol; 1989 Feb; 49(2):297-9. PubMed ID: 2733266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of isosorbide dinitrate and mononitrates in patients with renal failure.
    Bogaert MG; Rosseel MT; Boelaert J; Daneels R
    Eur J Clin Pharmacol; 1981; 21(1):73-6. PubMed ID: 7333349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and tissue levels of [14C]isosorbide dinitrate after oral and intravenous administration to rat.
    Reed DE; Akester JM; Prather JF; Tuckosh JR; McCurdy DH; Yeh C
    J Pharmacol Exp Ther; 1977 Jul; 202(1):32-7. PubMed ID: 874817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
    Geigenberger A; Degen J; Maier-Lenz H
    Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fate of orally given isosorbide dinitrate in man: factors of variability.
    Bogaert MG; Rosseel MT
    Z Kardiol; 1983; 72 Suppl 3():11-3. PubMed ID: 6141676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of isosorbide dinitrate and its metabolites in plasma by gas chromatography on a capillary column with electron-capture detection.
    Michel G; Fay L; Prost M
    J Chromatogr; 1989 Aug; 493(1):188-95. PubMed ID: 2778011
    [No Abstract]   [Full Text] [Related]  

  • 13. Patterns of isosorbide dinitrate and glyceryl trinitrate metabolites formed by selected segments of the rabbit gastrointestinal tract.
    Tam GS; MacMillan H; Bennett BM; Marks GS; Brien JF; Nakatsu K
    Can J Physiol Pharmacol; 1988 Feb; 66(2):166-70. PubMed ID: 3130974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of organic nitrates.
    Bogaert MG
    Clin Pharmacokinet; 1983; 8(5):410-21. PubMed ID: 6414751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
    Laufen H; Aumann M; Leitold M
    Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of orally given isosorbide dinitrate in cirrhotic patients.
    Bogaert MG; Rosseel MT; Elewaut A
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):491-2. PubMed ID: 6500768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics, effect and tolerance of isosorbide dinitrate and isosorbide-5-mononitrate in healthy persons].
    Abshagen U; Spörl-Radun S; Betzien G; Kaufmann B; Endele R
    Med Welt; 1981 Apr; 32(14A):508-16. PubMed ID: 7242310
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of isosorbide dinitrate biotransformation in various tissues of the rabbit by capillary column gas-liquid chromatography.
    Tam GS; Nakatsu K; Brien JF; Marks GS
    Biopharm Drug Dispos; 1987; 8(1):37-45. PubMed ID: 3580511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer aspects of the pharmacokinetics of organic nitrates.
    Chasseaud LF
    Z Kardiol; 1983; 72 Suppl 3():20-3. PubMed ID: 6666223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
    Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.